MedPath

DEXAMETHASONE AND COGNITIVE DECLINE : UPCOMING WONDER DRUG

Not Applicable
Conditions
Health Condition 1: C569- Malignant neoplasm of unspecifiedovary
Registration Number
CTRI/2018/11/016474
Lead Sponsor
AIIMS
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

undergoing any open abdominal surgeries of more than 2 hours with a minimum educational standard of fifth standard.

Exclusion Criteria

those with contraindications to dexamethasone and those who deny to participate in the study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath